Julia Watkins, MD
Gynecology · Little Rock, ARNPI 1891738373
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 224 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations.
Across 224 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$439
- Astellas Pharma US Inc$399
- AbbVie$385
- Pfizer$338
- Sumitomo Pharma America, Inc.$301
- Bayer$253
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,72594%
- Education$1905%
- Gifts$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 27 | $439 |
| Astellas Pharma US Inc | 16 | $399 |
| AbbVie(2 entities) | 23 | $385 |
| Pfizer | 24 | $338 |
| Sumitomo Pharma America, Inc. | 13 | $301 |
| Bayer | 13 | $253 |
| Amgen | 14 | $223 |
| Myovant Sciences Inc. | 14 | $197 |
| Exeltis, USA Inc. | 10 | $162 |
| Therapeuticsmd, Inc. | 7 | $126 |
| Organon | 5 | $109 |
| Duchesnay USA Incorporated | 7 | $102 |
| Merck | 6 | $100 |
| AMAG Pharmaceuticals, Inc. | 6 | $90 |
| Evofem Biosciences, Inc. | 4 | $73 |
| Hologic Sales And Service, LLC | 4 | $60 |
| Mylan Pharmaceuticals Inc. | 4 | $58 |
| Avion Pharmaceuticals | 3 | $53 |
| Aspira Women's Health Inc | 1 | $50 |
| Agile Therapeutics, Inc. | 3 | $49 |
| Radius Health, Inc. | 2 | $42 |
| GE HealthCare | 1 | $39 |
| Scynexis, Inc. | 2 | $38 |
| Millicent US Inc | 2 | $38 |
| Minerva Surgical, Inc | 2 | $36 |
| Lupin Inc. | 2 | $29 |
| Roche Diagnostics Corporation | 1 | $28 |
| Ascend Therapeutics US, LLC | 2 | $25 |
| Integra Lifesciences Corporation | 1 | $24 |
| Mycovia Pharmaceuticals, Inc. | 1 | $22 |
| Biogen | 1 | $20 |
| Coopersurgical, Inc. | 1 | $18 |
| Vertex | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
How this compares
$3,953 in reported general payments places this provider in the 85th percentile of 26 gynecology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 59 | $21,605 |
| Estradiol | 492 | $19,113 |
| Estradiol (Twice Weekly)Estradiol | 61 | $5,386 |
| Raloxifene Hcl | 98 | $4,541 |
| DottiEstradiol | 30 | $3,573 |
| Alendronate Sodium | 353 | $2,636 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 18 | $2,548 |
| ValacyclovirValacyclovir Hcl | 47 | $1,599 |
| Clobetasol Propionate | 41 | $1,511 |
| ProgesteroneProgesterone, Micronized | 44 | $1,098 |
| Ibandronate Sodium | 20 | $621 |
| Medroxyprogesterone Acetate | 37 | $546 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $418 |
| Escitalopram Oxalate | 25 | $273 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $266 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $338 | $21,60559 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 26 gynecology providers in Arkansas.
Other gynecology in Little Rock
- Angela MylesLittle Rock$5K
- William GreenfieldLittle Rock$4K
- Mamie OwensLittle Rock$2K
- Francisco BatresLittle Rock$1K
- Karen KozlowskiLittle Rock$70
- Amy PhillipsLittle Rock$42
- Sharon KeithLittle Rock$12
- William SmithMountain Home$6K
- Michael CarozzaArkadelphia$2K
- Angela CurryFayetteville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.